Literature DB >> 2912509

Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type.

W C Drevets1, E H Rubin.   

Abstract

Delusions, misidentifications and hallucinations occur frequently throughout the course of senile dementia of the Alzheimer type (SDAT). Rates of psychosis among subjects with moderate to severe SDAT range from 42% to 84% in our study group; at least half of persons with SDAT with no prior psychiatric history will display psychosis at some point during the course of dementia. Furthermore, psychotic symptoms are associated with accelerated cognitive deterioration, but not with increased mortality.

Entities:  

Mesh:

Year:  1989        PMID: 2912509     DOI: 10.1016/0006-3223(89)90145-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  33 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Clinical characteristics of community-dwelling black Alzheimer's disease patients.

Authors:  D G Harwood; W W Barker; R L Ownby; R Duara
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

3.  National patterns of dementia treatment among elderly ambulatory patients.

Authors:  Mary K Maneno; Euni Lee; Anthony K Wutoh; Ilene H Zuckerman; Patrice Jackson; Fredric A Lombardo; Kenneth R Scott; Zhenyi Xue
Journal:  J Natl Med Assoc       Date:  2006-03       Impact factor: 1.798

Review 4.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 5.  New atypical antipsychotics. Experience and utility in the elderly.

Authors:  R A Sweet; B G Pollock
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

Review 6.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Factors associated with psychotic symptoms in Alzheimer's disease.

Authors:  N Hirono; E Mori; M Yasuda; Y Ikejiri; T Imamura; T Shimomura; M Ikeda; M Hashimoto; H Yamashita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

8.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

9.  The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.

Authors:  Elise A Weamer; James E Emanuel; Daniel Varon; Sachiko Miyahara; Patricia A Wilkosz; Oscar L Lopez; Steven T Dekosky; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2008-09-25       Impact factor: 3.878

Review 10.  Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?

Authors:  Subramoniam Madhusoodanan; Payal Shah; Ronald Brenner; Sanjay Gupta
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.